Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Erhan Ararat

Concepts (102)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
11
2015
1248
1.140
 Why?
Organoids
2
2022
41
1.030
 Why?
Anti-Asthmatic Agents
1
2023
31
0.930
 Why?
Metformin
1
2023
66
0.880
 Why?
Lung
3
2022
507
0.790
 Why?
Asthma
1
2023
293
0.710
 Why?
Aspirin
2
2011
127
0.690
 Why?
Cystic Fibrosis
1
2021
157
0.680
 Why?
Diabetes Mellitus
1
2021
307
0.610
 Why?
Neoadjuvant Therapy
3
2013
125
0.480
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2011
1056
0.370
 Why?
Diphosphonates
1
2010
96
0.360
 Why?
Neoplasm Metastasis
1
2010
252
0.350
 Why?
Imidazoles
1
2010
142
0.350
 Why?
Protein Phosphatase 1
1
2009
6
0.350
 Why?
Losartan
1
2009
28
0.350
 Why?
Mitogen-Activated Protein Kinase 3
1
2009
55
0.350
 Why?
Mitogen-Activated Protein Kinase 1
1
2009
55
0.350
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2010
142
0.340
 Why?
Angiotensin II Type 1 Receptor Blockers
1
2009
46
0.340
 Why?
Isoenzymes
1
2009
177
0.330
 Why?
MAP Kinase Signaling System
1
2009
133
0.330
 Why?
Genetic Predisposition to Disease
1
2011
570
0.310
 Why?
Antineoplastic Agents
2
2011
1300
0.250
 Why?
Adrenal Cortex Hormones
1
2023
95
0.220
 Why?
Spinocerebellar Ataxias
1
2022
7
0.220
 Why?
Home Care Services
1
2023
79
0.220
 Why?
Humans
18
2023
54246
0.210
 Why?
Adolescent
3
2023
6885
0.200
 Why?
Body Height
1
2021
76
0.200
 Why?
Young Adult
4
2023
4308
0.200
 Why?
Anthracyclines
2
2011
25
0.190
 Why?
Respiration, Artificial
1
2023
285
0.190
 Why?
Disease Progression
1
2023
913
0.190
 Why?
Nutritional Status
1
2021
158
0.190
 Why?
Child
2
2023
7337
0.180
 Why?
Incidence
2
2011
1082
0.150
 Why?
Female
13
2015
28418
0.140
 Why?
Adult
5
2023
14182
0.140
 Why?
Multiple Myeloma
1
2010
3035
0.130
 Why?
Muscular Dystrophy, Duchenne
1
2015
15
0.130
 Why?
Receptors, Progesterone
2
2013
57
0.120
 Why?
Receptor, erbB-2
2
2013
79
0.120
 Why?
Cardiomyopathies
1
2015
129
0.120
 Why?
Receptors, Estrogen
2
2013
131
0.120
 Why?
Axilla
1
2013
101
0.110
 Why?
Retrospective Studies
3
2021
6432
0.110
 Why?
Prognosis
3
2015
2118
0.110
 Why?
Child, Preschool
1
2021
4146
0.110
 Why?
Heart
1
2015
360
0.110
 Why?
Lymphatic Metastasis
1
2013
256
0.110
 Why?
Survival Rate
2
2013
951
0.100
 Why?
Phenotype
1
2015
820
0.100
 Why?
Dacarbazine
1
2011
10
0.100
 Why?
Opportunistic Infections
1
2011
58
0.100
 Why?
Deoxycytidine
1
2011
28
0.100
 Why?
Antineoplastic Agents, Alkylating
1
2011
74
0.100
 Why?
Phthalazines
1
2011
19
0.100
 Why?
Genes, BRCA1
1
2011
24
0.100
 Why?
Fluorouracil
1
2011
61
0.100
 Why?
Lymph Nodes
1
2013
284
0.100
 Why?
Drugs, Generic
1
2010
6
0.100
 Why?
Neoplasm Recurrence, Local
2
2013
644
0.090
 Why?
Taxoids
1
2010
45
0.090
 Why?
Antineoplastic Agents, Hormonal
1
2010
49
0.090
 Why?
Tamoxifen
1
2010
60
0.090
 Why?
Piperazines
1
2011
116
0.090
 Why?
Captopril
1
2009
13
0.090
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
82
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
99
0.080
 Why?
Chemotherapy, Adjuvant
3
2015
119
0.080
 Why?
Enzyme Activation
1
2009
329
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
140
0.080
 Why?
Aorta
1
2009
177
0.080
 Why?
Ventricular Function, Left
1
2009
181
0.080
 Why?
Age Factors
1
2011
1195
0.080
 Why?
Follow-Up Studies
1
2011
2387
0.070
 Why?
Myocardial Infarction
1
2009
424
0.060
 Why?
Rats, Sprague-Dawley
1
2009
1663
0.060
 Why?
Apoptosis
1
2010
1300
0.060
 Why?
Mutation
1
2011
1501
0.060
 Why?
Treatment Outcome
2
2013
5604
0.060
 Why?
Respiration
1
2023
99
0.060
 Why?
Heart Failure
1
2009
541
0.060
 Why?
Tracheostomy
1
2023
81
0.050
 Why?
Rats
1
2009
3415
0.050
 Why?
Stem Cells
1
2022
193
0.050
 Why?
Epithelial Cells
1
2022
255
0.050
 Why?
Animals
2
2022
14385
0.050
 Why?
Cell Differentiation
1
2022
720
0.040
 Why?
Male
3
2015
27312
0.030
 Why?
Respiratory Function Tests
1
2015
98
0.030
 Why?
Aged
3
2013
10041
0.030
 Why?
Neoplasm Invasiveness
1
2013
295
0.030
 Why?
Disease-Free Survival
1
2013
485
0.030
 Why?
Mice
1
2022
6413
0.020
 Why?
Chemistry, Pharmaceutical
1
2010
39
0.020
 Why?
Arthralgia
1
2010
50
0.020
 Why?
Drug Administration Schedule
1
2010
401
0.020
 Why?
Middle Aged
2
2013
13070
0.020
 Why?
Risk Factors
1
2015
3930
0.020
 Why?
Aged, 80 and over
1
2013
3429
0.020
 Why?
Ararat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (102) concept(s)
_
Co-Authors Expand Description
See all (7) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department